Sponsor Quotes

Sponsor Quotes

“Federal money invested in NIH improves the lives of every American family by supporting life-saving research that leads to treatments and cures.  These investments also lead to jobs and economic growth throughout America.  Given the tragic toll of death and disease on our nation, Congress must provide consistent and robust funding for NIH. There are too many patients to be patient.”

Richard Turnman, PhD, RN, FAAN
President, Advancing Cures for Today (Act) for National Institues of Health (NIH)


“The National Institutes of Health (NIH) is the world’s largest source of biomedical research funding and its funded work touches us at every stage of our lives. NIH-funded research has illuminated the underpinnings of cancer, heart disease, and infectious diseases such as COVID-19 that have led to the development of life-changing diagnostics and treatments. There is so much more that needs to be done, especially to fix structural inequities in research and access to care, and the NIH needs more support to make it happen. There is no more important investment Congress can make than in our nation’s health and well-being.”

Michael Ward
Vice President of Public Policy and Government Relations, Alliance for Aging Research


“As we have witnessed during this public health emergency, sustained and increased funding for biomedical and behavioral research is critical to supporting scientific discoveries that promote better health and wellness. The National Institute of Nursing Research is on the frontlines of this work. We thank our nurse scientists who are advancing evidence-based interventions and leading translational research that addresses health equity, social determinants of health, population health, and health promotion.”

Deborah Trautman, PhD, RN, FAAN
President and Chief Executive Officer, American Association of Colleges of Nursing


“NIH is an indispensable part of the biomedical research enterprise, supporting a robust portfolio of basic research that is the foundation for the development of vaccines, treatments, and cures.  Discoveries made by NIH-funded immunologists have helped lead to many critically important advances, including most recently the rapid development of vaccines against COVID-19 and of numerous immunotherapies to treat a wide range of cancers.  NIH’s significant investment in training and supporting early career researchers also helps ensure a strong pipeline of immunologists and other research scientists who can help the U.S. maintain its preeminent role in advancing medical research.”

Mark M. Davis, PhD
President, American Association of Immunologists


“Cancer research saves lives. We are in an unprecedented time, wherein the gap between discovery and clinical intervention has narrowed, and emboldened a generation of new cancer researchers to strive for better anti-cancer strategies. Despite considerable gains, much work remains to reduce the burden of cancer. Federal funding is essential for progress to continue.”

Karen Knudsen, PhD, ABPP
Chief Executive Officer, American Cancer Society Cancer Action Network (ACS CAN)


“Our Nation’s children and adolescents have experienced higher anxiety, fear, and stress rates due to the COVID-19 pandemic. Increased NIH-supported pre-clinical and clinical research is essential to address the increasing mental health challenges young people face, including recognizing the disproportionate burden borne by children and adolescents from marginalized communities of color. APA is grateful for Congress’ support of NIH and psychological science and encourages it to provide continued consistent, steady, sustainable support so that we can respond to the challenges and growing demands surrounding our youth’s mental health.”

Mitch Prinstein, PhD, ABPP
Chief Science Officer, American Psychological Association


“NIH’s investment in biomedical research is crucial to our nation’s capacity to respond to public health crises. The recent emergence of novel infectious diseases such as Covid-19 and Monkeypox emphasizes the critical need for advancements in clinical research and support for the scientific community. This funding further enables the development and advancement of cutting-edge treatments for life-threatening hematologic diseases, including blood cancers and sickle cell disease.”

Jane N. Winter, MD
President, Federal Affairs, American Society of Hematology


“Federal funding for human genetics and genomics research is enabling new insights into the structure of, and variation in, the human genome and leading to new discoveries in understanding, preventing, and treating disease. Genomic science can improve human health and advance health equity through the deliberate, meaningful inclusion and participation of individuals from diverse groups in research. Sustained funding increases for NIH are critical to ASHG’s mission that people everywhere realize the benefits of human genetics and genomics research.”

Brendan Lee, MD, PhD
President-Elect, American Society of Human Genetics


“A bipartisan commitment to robust funding for the National Institutes of Health (NIH) and National Cancer Institute (NCI) is key to progress. Stable, predictable funding increases for the NIH and NCI accelerate lifesaving discoveries and support high quality care at AACI’s 105 member cancer centers.”

Jennifer W. Pegher
Executive Director, Association of American Cancer Institutes


“The groundbreaking medical research supported by the NIH nationwide generates medical discoveries that change the lives of patients, families, and communities everywhere. More than 50% of NIH-funded research takes place at the nation’s medical schools and teaching hospitals, leading to lifesaving vaccines and therapeutics, cures for diseases, and improved patient care. We are proud of the role that NIH and academic medicine play in helping Americans live longer, healthier lives.”

David J. Skorton, MD
President and Chief Executive Officer, Association of American Medical Colleges


“The American people’s return on investment for NIH-supported research is immeasurable. NIH has partnered with America’s leading research universities for decades to fund and conduct the basic research that has led to life-saving technologies – such as the mRNA vaccines that are helping us overcome the COVID-19 pandemic – and that has improved the health and lives of Americans through new treatments and therapies to treat cancer and other chronic diseases. These and other innovations and the economic growth that accompanies them would never occur without government investment in NIH-sponsored fundamental research. For the good of our nation and the entire world, that investment must continue.”

Barbara R. Snyder
President, Association of American Universities


“The cancer community has made monumental progress to conquer cancer over the past few decades, with new discoveries and advancements that are leading to more lives saved. Robust and sustained federal research funding is needed to ensure that the vision of preventing and curing cancer is realized, and that every patient who has faced cancer has equitable access to high-quality care. We call on Congress to invest in more funding for the National Institutes of Health and National Cancer Institute to create even more progress against cancer.”

Lori J. Pierce, MD, FASTRO, FASCO
Chair of the Board, Association for Clinical Oncology


“Thanks to historic Alzheimer’s and dementia research funding increases, scientists are able to work at a more rapid pace to advance the understanding of the disease, explore ways to reduce risk, uncover new biomarkers for early diagnosis and drug targeting, and develop potential treatments. This investment directly empowers researchers to explore new pathways that could yield promising discoveries for the more than 6 million Americans living with Alzheimer’s. At any given moment, discovery is happening.”

Rachel Conant
Vice President, Alzheimer’s Association


“California Life Sciences is proud to join the Rally for Medical Research and to advocate for robust investment in the National Institutes of Health. Public investment in basic research is an irreplaceable element of developing lifesaving cures and improving patient qualify of life.  We applaud Congress’s bipartisan commitment to investing in American leadership in health and medical research and encourage legislators to continue this legacy. We’re proud that California is at the center of our country’s leading life sciences work: Our state is home to ten of the top hundred leading universities in the world, according to the Shanghai Index, and California institutions accounted for 15% of total NIH funding in 2021.”

Mike Guerra
President and Chief Executive Officer, California Life Sciences


“Look in your medicine cabinet. Do you see a medication for treating a chronic illness or preventing disease? Chances are you can thank the NIH for that. Think about someone who has survived cancer. If not for the NIH, that person might not be with us. Or consider the future of a friend or family member with Alzheimer’s disease, a heart condition, or mental illness. Where will we find the treatments to alleviate their suffering? The answer almost certainly involves the NIH.”

Katrina Armstrong, MD
Chief Executive Officer and Dean, Columbia University Irving Medical Center


“We are so thankful for the continued Congressional support and commitment to cancer research funding. Federal funding for biomedical and cancer research from the NIH and the NCI is vital to our work at Dana-Farber to advance the science, care, and prevention of cancer for all patients. These investments can lead to transformative discoveries that can save lives. I am proud to once again join my colleagues from across the country as we come together to call on Congress to make funding at the NIH a national priority.”

Laurie H. Glimcher, MD
President and Chief Executive Officer, Dana-Farber Cancer Institute


“Research support provided by the NIH is foundational to America’s biomedical enterprise.  As the largest public funder of biomedical research worldwide, the NIH is helping people live longer, making diseases less deadly, and developing an array of preventions and treatments. NIH efforts expand knowledge through basic research that industry can further develop and cultivates the biomedical workforce from early career researchers to academic faculty.”

Kevin C. Kregel, PhD
President, Federation of American Societies for Experimental Biology (FASEB)


“NIH funding is imperative to fueling lifesaving progress in cancer and infectious disease research. This support drives innovation, and with new treatments and cures on the horizon, leads to lifesaving discoveries. Robust and sustained federal investment accelerates research in prevention, detection, and treatment for many cancers and other diseases at Fred Hutch. Continued investments in NIH ensure that patients and their families will benefit from innovative research to better understand, prevent, and ultimately eliminate cancer and infectious diseases.”

Thomas J. Lynch Jr., MD
President and Director, Fred Hutchinson Cancer Center


“It’s difficult to overstate the importance of the National Institutes of Health. Karyopharm’s commitment to developing new therapies for patients with cancer is deeply rooted in medical research. The NIH’s mission to maximize research opportunities is fundamental to enhance health and reduce illness for patients and their families that we serve every day.”

Reshma Rangwala, MD, PhD
Executive Vice President and Chief Medical Officer, Karyopharm Therapeutics


“A sustained robust investment in evidence-based research and data collection programs at NIH is critical to addressing our nation’s maternal and infant health crisis. These critical investments assist in speeding the development of life-saving treatments for moms and babies. March of Dimes is a proud partner on the ‘Rally for Medical Research Hill Day’ and we look forward to meeting with bipartisan Members of Congress to discuss the importance of maintaining a strong commitment to research to meet current and future public health challenges.”

Stacey Y. Brayboy
Senior Vice President, March of Dimes 


“Thanks to the transformative research that is funded by NIH, there is real hope on the horizon for improving outcomes and even curing some forms of cancer and other devastating medical conditions. Innovative new treatments are emerging every day. NIH supports research that improves the health of our entire nation, creates jobs, boosts the economy and ensures that America remains a global leader in health innovation.”

John L. Cleveland, PhD
Center Director and Executive Vice President, Moffitt Cancer Center


<“The impact of NIH-funded medical research cannot be overstated. For a disease like eczema – specifically atopic dermatitis, which is chronic, heterogeneous and without a cure – we still have a long way to go to improve the lives of the over 31 million Americans affected. NIH-funded research is critical to a deeper, holistic understanding of eczema that will drive better therapies, better care, better outcomes – and one day, potentially a cure.”

Julie Block
President and Chief Executive Officer, National Eczema Association


“The National Institutes of Health seeds progress that saves lives and reduces suffering. COVID-19 is a grim reminder that our very future as a nation and global community hinge on continuously pushing the boundaries of science. Your advocacy is not just important, it is crucial. Thank you for who you are and what you do.”

Mary Woolley
President and Chief Executive Officer, Research!America


“Childhood cancer research uniquely depends on the federal government as its primary source of funding. Thanks to greater awareness and advocacy, the National Cancer Institute has more than doubled its investment in childhood cancer research in recent years. Despite these needed resources, 1 in 5 children diagnosed with cancer in the United States will not survive. The St. Baldrick’s Foundation is proud to join with the research community to urge Congress to provide additional increases for the National Institutes of Health to fund life-saving research and to develop new, safer therapies for kids with cancer.”

Kathleen Ruddy
Chief Executive Officer, St. Baldrick’s Foundation


“Thanks to NIH-funded research, advances in cancer care have moved at a phenomenal pace over the last several years. Today, more people are surviving cancer than ever before. Sustained and predictable funding helps us keep this momentum, leading to more breakthrough discoveries, cures and lives saved.”

Roy Jensen, MD
Vice Chancellor and Director, The University of Kansas Cancer Center


“Sustained NIH funding and increased funding for new initiatives drive discoveries in oncology and in many other areas vital to our heath. By continuing to apply our knowledge of cancer biology, bioinformatics, viral oncology and population science, we can positively influence the health of our nation. Our recent experiences with the COVID 19 pandemic have shown that funding is critical in sustaining the health and safety of our population, including racial and ethnic minority communities, rural communities and underserved communities.”

Alan E. Tomkinson, PhD
Interim Director and Chief Executive Officer, The University of New Mexico Comprehensive Cancer Center


“NIH funding is helping UCLA Health translate discoveries that can improve the of health of our region’s diverse population. Thanks in part to the NIH, we have received FDA-approval for 11 cancer mediations since 2012. The NIH also supports cutting edge clinical advances, like our work to improve organ, hand and face transplantation. We applaud Congress for its steadfast, bipartisan support of the National Institutes of Health.”

John Mazziotta, MD, PhD
Chief Executive Officer and Vice Chancellor, UCLA Health


“Weill Cornell Medicine is proud to support the 10th Annual Rally for Medical Research Hill Day. Robust funding of the National Institutes of Health fuels the discoveries that save lives. We applaud Congress for previous increases to the budget of this integral biomedical research agency. As seen throughout the COVID-19 pandemic and when considering the known and unknown public health threats we face, our nation depends on it.”

Augustine M.K. Choi, MD
Dean, Weill Cornell Medicine